Carcinoid Syndrome - 50 Studies Found
Terminated |
: Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome : Carcinoid Syndrome : 2009-04-20 : Drug: Octreotide short acting octreotide |
Completed |
: An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome : Carcinoid Syndrome : 2008-10-15 :
|
Terminated |
: Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome : Carcinoid Syndrome : 2009-11-24 : Drug: BIM 23A760 BIM 23A760 is a solution at a concentration of 5 mg/mL ready for subcutaneous injection |
Completed |
: TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) : Carcinoid Syndrome : 2012-08-30 :
|
Active, not recruiting |
: Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms : Carcinoid Syndrome : 2013-12-31 : Drug: Telotristat etiprate tablets (250 mg) Other Name: LX1606 |
Completed |
: Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy : Carcinoid Syndrome : 2009-02-25 :
|
Completed |
: A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea :
: 2010-10-20 |
Completed |
: An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males : Carcinoid Syndrome : 2013-08-27 : Drug: 500 mg [14C]-LX1606 500 mg dose of LX1606 containing a target dose of 3.32 Megabecquerel (MBq) of |
Completed |
: Azilect + Antidepressant Chart Review : Serotonin Syndrome : 2009-08-06 :
|
Completed |
: Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor :
: 2006-12-13 :
|